Comparison

L002 European Partner

Item no. TMO-T11807-5mg
Manufacturer TargetMol
CASRN 321695-57-2
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles COc1ccc(cc1)S(=O)(=O)ON=C1C=C(C)C(=O)C(C)=C1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 321695-57-2
Shipping Condition Cool pack
Available
Manufacturer - Targets
Histone Acetyltransferase|||STAT
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
321.35
Description
L002, a potent, cell-permeable, reversible, and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 μM, directly binds the acetyl-CoA pocket and competitively inhibits the FATp300 catalytic domain. By blocking histone acetylation, p53 acetylation, and STAT3 activation, L002 shows potential in the treatment of hypertension‐induced cardiac hypertrophy and fibrogenesis.
Pathways
Chromatin/Epigenetic|||Stem Cells|||JAK/STAT signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close